ALLOGENE THERAPEUTICS INC. - COMMON STOCK
2.1750
22-November-24 14:11:44
15 minutes delayed
Stocks
+0.0650
+3.08%
Today's range
2.0900 - 2.2300
ISIN
N/A
Source
NASDAQ
-
Allogene Therapeutics Announces Participation in December Investor Conferences
19 Nov 2024 07:30:00 By Nasdaq GlobeNewswire
-
Allogene Therapeutics Reports Third Quarter 2024 Financial Results and Business Update
07 Nov 2024 15:02:00 By Nasdaq GlobeNewswire
-
07 Nov 2024 09:00:00 By Nasdaq GlobeNewswire
-
05 Nov 2024 08:10:30 By Nasdaq GlobeNewswire
-
Allogene Therapeutics Announces Participation in November Investor Conferences
04 Nov 2024 07:30:00 By Nasdaq GlobeNewswire
-
Allogene Therapeutics to Report Third Quarter 2024 Financial Results and Provide Business Update
30 Oct 2024 07:30:00 By Nasdaq GlobeNewswire
-
Allogene Therapeutics Announces Participation in the Goldman Sachs Cell Therapy Day Conference
30 Sep 2024 07:30:00 By Nasdaq GlobeNewswire
-
Allogene Therapeutics Announces Participation in Upcoming Investor Conferences
08 Aug 2024 07:30:00 By Nasdaq GlobeNewswire
-
Allogene Therapeutics Reports Second Quarter 2024 Financial Results and Business Update
07 Aug 2024 15:02:54 By Nasdaq GlobeNewswire
-
Allogene Therapeutics to Report Second Quarter 2024 Financial Results and Provide Business Update
31 Jul 2024 07:30:00 By Nasdaq GlobeNewswire
-
Allogene Therapeutics Announces Participation in the TD Cowen 5th Annual Oncology Innovation Summit
23 May 2024 07:30:00 By Nasdaq GlobeNewswire
-
Allogene Therapeutics Announces Pricing of $110 million Offering of Common Stock
13 May 2024 15:47:42 By Nasdaq GlobeNewswire
-
Allogene Therapeutics Reports First Quarter 2024 Financial Results and Business Update
13 May 2024 15:01:00 By Nasdaq GlobeNewswire
-
Allogene Therapeutics to Report First Quarter Financial Results and Provide Business Update
06 May 2024 07:30:00 By Nasdaq GlobeNewswire
-
26 Apr 2024 07:30:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >